Panel criticizes popular daytime sedatives in FDA study
An FDA advisory panel finds most nonprescription sedatives ineffective or dangerous with antihistamines often reducing alertness and coordination. Four members favor a three year stay for reformulation, while three seek an outright ban. The report calls for stricter labeling and FTC ad monitoring.
MENTIONED IN THIS ARTICLE
JGNN
Stowell
Associated Press
Washington
Food and Drug Administration
Atl
Karl Rickels
Philadelphia
FDA
Lrada
Industr
Ass Aviation
James D. Cope
Rickels
University of Pennsylvania Hospital
Also Mentioned on This Page
Strock’s Trim Shop
Monterey
Scott
Strock Bros
PPS
Lata Anderson
Main Street
Anderson
Wallaway
Walt Haugehyde
Wardlon
Dinette
Sey
Serean
Stewart’s Furniture
Daleville
Miles Nervine
United States
Canada
U. S. Postal Service
Miles Laboratories
Food and Drug
Alexander M. Schmidt
J.C. Williams Company
Whitehall Laboratories
Gerrard Cosmetics
Federal Trade Commission
Wewitt
Meriman
Park Rd
Nichol Ave
Anderson Ee
Men's Shoes
Meridian Plaza
Mounds Mall
Ladies Shoes
Sporties